Branched-chain amino acids and respiration.
A series of investigations suggest a specific role for BCAA in the regulation of respiration. In vitro incubation studies have shown that BCAAs improve the recovery of muscle force after fatigue. Further investigations revealed that leucine plays a key role in this action and acts in a manner not dependent on its use as an energy substrate. In humans, solutions enriched with BCAA have decreased PCO2 and stimulated the ventilatory response to hypercapnia, thereby corresponding to an enhanced ventilatory sensitivity with the administration of BCAA. The mechanisms for these actions are unknown. The most viable hypothesis is based on the ability of BCAA to decrease the synthesis of serotonin due to altered transport of AAs, including tryptophan, to the brain. Clinical studies have suggested a potency of BCAA in the treatment of respiratory dysfunction of preterm infants, as well as of patients with sleep apnea related to various disease states. The clinical applications of BCAA-enriched mixtures in respiratory diseases are still experimental, and many controversies exist concerning the validity of BCAA in clinical practice. Most TPN regimens contain BCAA approximating the average intake of BCAA in the Western diet. The question therefore remains whether additional BCAA supplementation is useful to achieve the suggested metabolic and pharmacological effects. Meticulous future studies are needed to establish the therapeutic value of BCAA in the treatment of various respiratory functions.
Manner
T
T
Department of Anesthesiology, Mount Sinai School of Medicine, New York, New York 10029.
Wiese
S
S
Katz
D P
DP
Skeie
B
B
Askanazi
J
J
D000597:Amino Acids, Branched-Chain / Q000008:administration & dosage / Q000502:physiology* / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D007231:Infant, Newborn; D009132:Muscles / Q000502:physiology; D010084:Oxidation-Reduction; D012119:Respiration / Q000502:physiology*
D000597:Amino Acids, Branched-Chain